Generic Clearance for the Collection of Qualitative Feedback on Agency Service Delivery (NCI)

Department of Health and Human Services (DHHS), National Institutes of Health (NIH), and National Cancer Institute (NCI) seek to obtain OMB approval to extend the generic clearance to collect qualitative feedback on our service delivery for an additional three (3) years. This information collection activity has garnered qualitative customer and stakeholder feedback in an efficient, timely manner, to address the Administration’s commitment to improving service delivery. This generic has provided information about the National Cancer Institute’s customer or stakeholder perceptions, experiences, and expectations, provided an early warning of service issues or focused attention on areas where communication, training, or operations changes might improve product or service delivery. It has also allowed feedback to contribute directly to the improvement of program management. Feedback collected under this generic clearance provides helpful information but does not yield data that can be generalized to the overall population.

The latest form for Generic Clearance for the Collection of Qualitative Feedback on Agency Service Delivery (NCI) expires 2029-05-31 and can be found here.